Cellerant Therapeutics' Grant - VI Round

Cellerant Therapeutics raised a round of funding on September 15, 2011. Investors include Biomedical Advanced Research and Development Authority.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies…

Articles about Cellerant Therapeutics' Grant - VI Round: